Cognition Therapeutics, Inc.

Healthcare

NASDAQ:CGTX · NASDAQ Global Market

Market Cap $87.19M Beta 1.75 P/E (TTM) -5.5

$1.21 +0.83%

+$0.01 today

52W Low $0.25High $3.83

Vol 0.44M · Avg 1.22M

EPS (TTM)-$0.22

Biotechnology

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-68.5%

avg -49.9%

ROIC

-136.9%

avg -226.3%

ROA

-48.5%

avg -69.6%

Analysis

ROA is currently the strongest return metric at -48.5% versus its period average of -69.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management

Name	Title	Compensation	Tenure	Age	Shares Owned	Ownership %
Lisa Ricciardi	Chief Executive Officer, President & Director	$1.06M	—	66	$1.72M	2.33%
Anthony O. Caggiano	Chief Medical Officer	$742,634.00	—	56	$874,906.00	1.19%
John Brendan Doyle	Chief Financial Officer	$681,528.00	—	49	$618,942.00	0.84%
Bobby Horn	Corporate Controller	—	—	—	—	—
Steven A. Weissman	Vice President & Head of CMC	—	—	—	$48,500.00	0.07%
Anita Cornet	Head of Quality	—	—	—	—	—

Insider Trading

SEC Form 4 transactions — last 12 months

Management

Buys

$32,492.50

Sells

$0.00

Net Sentiment

+$32,492.50

Net buying

Most Active

Ricciardi Lisa

1 transactions

Date	Insider	Type	Shares	Price	Value
Apr 16, 2026	Ricciardi Lisa Direct	Buy	9.2K	$1.10	$10,092.50
Apr 16, 2026	Doyle John Brendan Direct	Buy	10.0K	$1.13	$11,300.00
Apr 16, 2026	Caggiano Anthony Direct	Buy	10.0K	$1.11	$11,100.00

Analysis

Insiders reported 3 buys worth $32,492.50 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $32,492.50. Ricciardi Lisa was the most active insider with 1 transactions.